OptimizeRx Partners with EvidenceCare to Deliver Real-time Medication Messaging to Hospitals
Apr 23, 2018 12:31 pm UTC| Business
ROCHESTER, Mich. and NASHVILLE, Tenn., April 23, 2018 -- OptimizeRx Corp. (OTCQB:OPRX), the nation’s leading provider of digital health messaging for the pharmaceutical industry, has partnered with EvidenceCare, a...
Apr 23, 2018 12:31 pm UTC| Business
CAMBRIDGE, Mass., April 23, 2018 -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, announced that two...
HempAmericana Announces Augusta CBD Oil Facility Now “Open for Business”
Apr 23, 2018 12:31 pm UTC| Business
NEW YORK, April 23, 2018 -- via OTC PR WIRE-- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is thrilled to announce that the new Vitalis R-200 high-capacity supercritical CO2 CBD Oil Extraction...
Apr 23, 2018 12:31 pm UTC| Business
MINNEAPOLIS, April 23, 2018 -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today...
Apr 23, 2018 12:31 pm UTC| Business
CHANDLER, Ariz., April 23, 2018 -- (NASDAQ:MCHP) -- Microchip Technology Incorporated, a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, today announced, that its notification to...
Capstone Announces the Appointment of Robert C. Flexon to its Board of Directors
Apr 23, 2018 12:31 pm UTC| Business
VAN NUYS, Calif.,, April 23, 2018 -- Capstone Turbine Corporation (www.capstoneturbine.com) (NASDAQ:CPST), the world’s leading clean technology manufacturer of microturbine energy systems, announced today the...
ARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration Agreement
Apr 23, 2018 12:31 pm UTC| Business
WESTMINSTER, Colo., April 23, 2018 -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases,...